Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Shares Soar on Rumors of a $6B Buyout Bid from Thermo Fisher

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Millipore climbed as high as $102.91 — a 44 percent rise from its Friday closing price of $71.34 — after a report from Bloomberg claimed that Thermo Fisher Scientific has made an unsolicited $6 billion bid to acquire the firm.

A Thermo Fisher spokesperson said the firm would not comment on the "rumor," and Millipore did not respond to a request for comment.

However, Reuters reported later in the day that a source had confirmed for them that Thermo Fisher had made the offer. Both news agencies said that Millipore has hired Goldman Sachs as a financial advisor in response to the bid.

In Monday afternoon trade, shares of Millipore pulled back some but were still up 21 percent at $86.17 on the New York Stock Exchange.

Millipore has a market cap of around $4.9 billion and recently reported full-year 2009 revenues of $1.65 billion.

Thermo Fisher earlier this month reported 2009 revenues of $10.11 billion, and it currently has a market cap of around $19.5 billion.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.